Page last updated: 2024-09-05

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Small Cell Lung Carcinoma

arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide has been researched along with Small Cell Lung Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carvalheiro, M; Corvo, ML; Cruz, MEM; Ferreira-Silva, M; Holovanchuk, D; Marinho, HS; Moreira, JN; Soares, H1

Other Studies

1 other study(ies) available for arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide and Small Cell Lung Carcinoma

ArticleYear
Antagonist G-targeted liposomes for improved delivery of anticancer drugs in small cell lung carcinoma.
    International journal of pharmaceutics, 2022, Jan-25, Volume: 612

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Liposomes; Lung Neoplasms; Mice; Oligopeptides; Small Cell Lung Carcinoma; Tissue Distribution

2022